Interestinglythe combined blockade of platelet GPIIb–IIIa and tumor cell–expressed αvβ3 is more effective at inhibiting tumor growth when compared with the single blockade of integrin receptors (73). The gene discussed is ITGA2B; the disease is neoplasm.